O&G Flashcards
sites for ectopic preganancy
fallopian tubes (97%) ovaries abdomen C-section scar
risk factor for ectopic pregnancy
previous ectopic
pelvic surgery - (C-section, appendectomy, sterilisation)
endometriosis
clamydia
presentation of ectopic preganancy
typically at 6-8 weeks after LMP vaginal bleeding pelvic discomfort pain when opening bowels hypovolaemic shock - hypotension, tachycardia
investigations for ectopic pregnancy
urine/serum beta HCG
transvaginal US
serial serum-hCG
explain serial beta-hCG use is ectopic pregnancy
use if US can’t find ectopic but it is suspected
increase > 60% sugest intrauterine pregnancy
<66% increase or <15% decrease suggest ectopic
>15% decrease suggests failing PUL
management of ectopic pregnancy
expectant management (conservative - wait for spontaneous resolution) medical management (Methotrexate) surgical management (salpingostomy or salpingectomy)
define miscarriage
any pregnancy loss before 24 weeks gestation
risk factors for miscarriage
old maternal age
PCO
smoking and alcohol
uterine malformations ( ascending UTIs, bicornuate)
cause of miscairrage
cervical incompetence/weakness
transplacental foetal infection - syphilis, rubella
rhesus isoimmunisation
explain rhesus isoimmunisation
Antibodies in the mothers blood attacks RBC in the foetus
Due to rhesus D antigen (RhD) on RBCs
Can only occur when all 3 apply
1) Mother is RhD negative
2) Foetus is RhD positive
3) Mother has previously been exposed to RhD+ blood and has become sensitised (previous pregnancy, miscarriage, ectopic, c-cestion)
what are the types of miscarriage
threatened inevitable incomplete complete delayed/missed septic recurrent
presentation of miscarriage
vaginal bleeding +/- clots
suprapubic pain
postcoital bleeding
investigations for miscarriage
serum beta hCG (drop of >50% in 48hrs suggests failing pregnancy
transvaginal US
A gestational sac, mean diameter >25, with a visible yolk sac
Crown-rump length of embryo > 7mm and no obvious foetal heart beat
Empty uterus (if ectopic is ruled out) = complete miscarriage
Retained tissue = incomplete miscarriage
rhesus blood group
cytogenetic of products of conception (in recurrent miscarriages)
Management of miscarriage
threatened or complete - analgesia + counselling + anti D
inevitable/incomplete/missed - above + manual evacuation, misoprostol (for bleeding), can consider conservative with antibiotics
examples of gestational trophoblastic disease
partial hydatidiform mole complete hydatidiform mole invasive mole choriocarcinoma placental site trophoblastic tumour
management of trophoblastic gestational disease
desired fertility - dilation and evacuation with mechanical suction with 12 month follow up and strict adherence to contraception
not desiring fertility: hysterectomy
management of viable twins in gestational trophoblastic disease
elective termination via dilation and evacuation
if termination not desired manage as a high risk pregnancy with close observation specifically for eclampsia and thyrotoxicosis
define hyperemesis gravidarum
persistent vomiting during pregnancy resulting in weight loss, ketosis, electrolyte disturbances and volume depletion
investigations for hyperemesis gravidarum
urine ketones
check for UTIs
U&Es, LFTs
USS - multiple pregnancies, molar pregnancies
management of hyperemesis gravidarum
IV fluids (avoid dextrose)
IV anti-emetics (ondansetron)
omeprazole
replace electrolytes/vitamins as required
define infertility
Primary = inability to achieve pregnancy after 12 months of regular unprotected sex Secondary = infertility after previously been pregnant
causes of male infertility
obstructive azoospermia - normal sperm production but not present in ejaculate (blockage of vas or epididymis, CF causing congenital absence of vas)
non-obstructive azoospermia - testicular failure (high FSH, low Testosterone) e.g. due to obesity, endocrinopathies, chemotherapy
XXY Klinefelter’s, Y microdeletions
unstimulated spermatogenesis - hypogonadotropic hypogonadism
causes of female infertility
anovulation due to
group 2 =hypothalamic pituitary ovarian axis dysfunction (PCOS, adrenal dysfunction, thyroid dysfunction)
group 1 = hypothalamic pituitary failure (weight, stress, exercise, kallmans, pituitary tumour, sheehans)
group 3 = ovarian failure (chemo/radiotherapy, turner’s)
tubal causes
scarring, obstruction, adhesions (STIs, ectopic pregnancies)
PID, endometriosis, fibroids, polyps
investigations for male infertility
FSH, testosterone karyotype (CF carrier, Y deletions) semen analysis (concentration, motility, morphology)
oligospermia = low sperm asthenospermia = immotile sperm teratospermia = abnormal morphology
investigations for female infertility
TV USS
cervical sear, chlamydia, gonorrhoea,
ovarian function (luteal phase progesterone, LH, FSH, anti mullerian hormone
hystero-salpingo-gram, hysteroscopy
management of infertility
lifestyle (smoking, alcohol, weight)
folic acid
group 2 - clomifene, letrozole, FSH injection
group 1 - gonadotrophin releasing hormone injections
ART (IUI, IVF, ICSI)
tubal catheterisation
surgical correction of epididymis blockage
types of epithelial ovarian cancers
High grad serous
Resembles fallopian tube mucosa
P53 and BRAC1 mututions
Those that arise from ovarian surface epithelium and Mullerian inclusion cysts
Endometrioid and clear cell – likely due to ovarian endometriosis, associated with PTEN loss
low grade serous – KRAS and BRAF mutations
risk factors for ovarian cancers
BRCA 1, 2, Lynch syndrome II
nulliparity, early menarche, late menopause
never on OCP
presentation of ovarian cancer
pelvic mass altered bowel habits abdominal pain early satiety urinary urgency
investigations for ovarian cancer
USS, CT CA125 >35 RMI cytology of plural or ascitic fluid biopsy, histology FIGO staging
management of ovarian cancer
surgery
chemotherapy - carboplatin, VEGF inhibitor, aromatase inhibitor
prophylactic bilateral Salpingo-oophrectomy
types of endometrial cancers
most commonly adenocarcinomas - 2 types - oestrogen excess (endometrial adenocarcinoma), non oestrogen excess (papillary serous, clear cell)
others = leiomyosarcomas, uterine carcinomas
risk factors for endometrial cancer
lynch syndrome obesity nulliparity HRT PCOS tamoxifen use
presentation of endometrial cancer
post menopausal bleeding
post coital bleeding
altered menstrual pattern
persistent vaginal discharge
investigations for endometrial cancer
Pelvic and transvaginal US - endometrial thickening >5mm
hysteroscopy and biopsy
CT CAP
management of endometrial cancer
total hysterectomy + bilateral salpingo-oopherectomy + lymphadenectomy
adjuvant vaginal brachytherapy or pelvic external beam radiotherapy
chemo for late stages, serous or clear cell
types of cervical cancer
80% squamous cell carcinoma
15% adenocarcinoma
4-5% Adenosquamous
<1% endometroid, clear cell, serous, neuroendocrine
risk factors for cervical cancer
HPV - strains 16, 18 highest risk smoking immunosuppression multiple sexual partners early onset sexual activity
describe the HPV vaccination program
against strains 6, 11, 16, 18
given to all females aged 11-13
2 s/c injections 6 months apart
describe the screening program for cervical cancer
pap smear
offered to women aged 25 - 65 (25-49 = every 3 years. 50-65 = every 5 years)
looks for precancerous lesions/cancerous cells at the transformation zone
includes HPV testing
presentation of cervical cancer
abnormal vaginal bleeding post coital bleeding mucoid/purulent discharge dyspareunia pelvic pain obstructive renal failure
investigations for cervical cancer
VE and speculum - masses, bleeding
colposcopy, biopsy, histology
HPV testing
CT/MRI/PET
FIGO staging for cervical cancer
I – confined to cervix
II – invades beyond uterus but not lower third of the vagina
III – involves lower third or extends to pelvic wall
IV – extends beyond the pelvis
management of cervical cancer
LLETZ/cone biopsy/trachelectomy + pelvic lymphadenectomy
radical hysterectomy
chemo and radiotherapy
types of vulval cancers
90% squamous cell carcinomas
others = adenocarcinomas, melanomas, BCC, sarcomas
describe VIN
vulval intraepithelial neoplasia (Classes I, II, III)
precursor to squamous carcinoma
Management of VIN
I = symptomatic relief after excluding invasive disease, eradiated HPV
II/III - surgical excision/laser ablation/chemical ablation (imiquimod)
plastic and reconstruction input
types of vulval squamous cell carcinoma
SSC associated with VIN
usually <60 y.o.
associated with cervical cancer and HPV 16/18
SSC associated with dermatoses
>60 y.o.
keratinised and well differentiated